AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Dashglim-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Dashak Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Dashglim-M2 Tablet SR

Glycemia-Duo SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Glycemia-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without medical consultation, risks elevated glucose levels and potential complications like kidney disease, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women must consult their doctor before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your physician.

Primary Ingredients of Dashglim-M2 Tablet SR

No information provided. Therefore, no rewriting is possible.

Uses of Dashglim-M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Dashglim-M2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dashglim-M2 Tablet SR with a meal.

Common Side effects of Dashglim-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dashglim-M2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dashglim-M2 Tablet SR whole; do not crush, chew, or divide it. Administer this medicine with food.

How Dashglim-M2 Tablet SR works:

Dashglim-M2 SR tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Dashglim-M2 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dashglim-M2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The extended-release Dashglim-M2 Tablet is contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Dashglim-M2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Dashglim-M2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Dashglim-M2 SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients experiencing mild to moderate liver dysfunction, initiate Dashglim-M2 SR tablet therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Dashglim-M2 Tablet SR :

Should you forget a Dashglim-M2 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dashglim-M2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Dashglim-M2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Dashglim-M2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Dashglim-M2 Tablet SR and seek immediate medical attention.
Dashglim-M2 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Dashglim-M2 SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Dashglim-M2 Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some researchers.
Dashglim-M2 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dashglim-M2 Tablet SR and alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Dashglim-M2 Tablet SR
65
MRP 75
13% off